Instead of simply masking the problem, the collection focuses on strengthening the hair fiber, improving manageability, and protecting against the everyday factors that can make thinning appear even more noticeable
The earliest it could hit the market would be late 2026, though it's more likely to drop in 2027
Mounjaro (tirzepatide) is a once-weekly GLP-1 injectable approved for Type 2 diabetes and, at higher doses, for weight management in adults with obesity
Pregnancy, certain digestive disorders, medication interactions, and other medical factors may affect treatment selection
Frequently Asked Questions Is HumeCare+ available in every state
Websites meeting inclusion criteria were selected for a product test buy protocol